Wells Fargo & Company »

Apellis Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.0M 139k 28.84
2024-06-30 $6.1M 160k 38.36
2024-03-31 $8.5M 145k 58.78
2023-12-31 $7.9M 133k 59.86
2023-09-30 $5.9M 156k 38.04
2023-06-30 $8.4M 92k 91.10
2022-12-31 $876k 17k 51.71
2022-09-30 $2.8M 41k 68.44
2022-06-30 $720k 16k 45.55
2022-03-31 $2.1M 41k 50.80
2021-12-31 $3.0M 64k 46.51
2021-09-30 $1.7M 51k 34.29
2021-06-30 $2.3M 36k 63.21
2021-03-31 $430k 10k 42.87
2020-12-31 $2.8M 48k 58.14
2020-09-30 $811k 27k 30.65
2020-06-30 $1.3M 41k 32.65
2020-03-31 $825k 31k 26.80
2019-12-31 $1.8M 59k 30.62
2019-09-30 $1.1M 46k 24.09
2019-06-30 $1.1M 44k 25.36
2019-03-31 $463k 24k 19.51
2018-12-31 $337k 26k 13.21
2018-09-30 $318k 18k 17.75
2018-06-30 $370k 17k 21.99
2018-03-31 $136k 6.1k 22.12
2017-12-31 $35k 1.6k 21.93